Saundra Pelletier

Chief Executive Officer at Evofem Biosciences.

Raised on Evofem Biosciences filings

$1.7M

of $2.4M offered across 2 Form D filings

Company

Biotech · San Diego, CA

Hormone-free on-demand contraceptive gel

Hormone-free on-demand contraceptive gel

Evofem Biosciences Form D filings
Filed	Security	Sold of offered	Filing
Jul 2, 2025	Equity	$925K/ $925K	Form D
Apr 15, 2025	Equity	$750K/ $1.5M	Form D

Also named on Evofem Biosciences filings